Browse By

Daily Archives: May 26, 2017

No Thumbnail

RIVERVIEW BANCORP, INC. (NASDAQ:RVSB) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

RIVERVIEW BANCORP, INC. (NASDAQ:RVSB) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Item 5.02 Departure of Directors or Certain Officers; Election ofDirectors; Appointment of Certain Officers; CompensatoryArrangements of Certain Officers. (a) On

No Thumbnail

FB Financial Corporation (NYSE:FBK) Files An 8-K Entry into a Material Definitive Agreement

FB Financial Corporation (NYSE:FBK) Files An 8-K Entry into a Material Definitive Agreement Item1.01 Entry into a Material Definitive Agreement. Amendment to Stock Purchase Agreement Overview of Amendment On May26, 2017, FB Financial Corporation, a Tennessee Corporation(the Company), and its wholly-owned banking subsidiary,FirstBank, entered into

No Thumbnail

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On

No Thumbnail

SANGAMO THERAPEUTICS, INC. (NASDAQ:SGMO) Files An 8-K Entry into a Material Definitive Agreement

SANGAMO THERAPEUTICS, INC. (NASDAQ:SGMO) Files An 8-K Entry into a Material Definitive Agreement Item1.01 Entry into a Material Definitive Agreement On May26, 2017, Sangamo Therapeutics, Inc. (the Company) enteredinto the Amended and Restated At-the-Market Offering ProgramSales Agreement (the Amended Sales Agreement) with Cowen andCompany, LLC

No Thumbnail

ContraVir Pharmaceuticals,Inc. (NASDAQ:CTRV) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

ContraVir Pharmaceuticals,Inc. (NASDAQ:CTRV) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Item 5.02 Departure of Directors or Certain Officers:Election of Directors; Appointment of Certain Officers;Compensatory Arrangements of Certain Officers On May25, 2017,